Impakter
  • Environment
    • Biodiversity
    • Climate Change
    • Circular Economy
    • Energy
  • FINANCE
    • ESG News
    • Sustainable Finance
    • Business
  • TECH
    • Start-up
    • AI & Machine Learning
    • Green Tech
  • Industry News
    • Entertainment
    • Food and Agriculture
    • Health
    • Politics & Foreign Affairs
    • Philanthropy
    • Science
    • Sport
  • Editorial Series
    • SDGs Series
    • Shape Your Future
    • Sustainable Cities
      • Copenhagen
      • San Francisco
      • Seattle
      • Sydney
  • About us
    • Company
    • Team
    • Partners
    • Write for Impakter
    • Contact Us
    • Privacy Policy
No Result
View All Result
Impakter logo
No Result
View All Result
COVID-19: Two Sides of China in Global Health

COVID-19: Two Sides of China in Global Health

Richard SeifmanbyRichard Seifman
December 30, 2020
in Health, Politics & Foreign Affairs, Society
0

Watching how the COVID-19 pandemic developed, it is fair to ask what was the role of China in global health: Was it the good guy or bad guy?

The Very Bad Side

We learned recently of the People’s Republic of China’s treatment of the brave young woman journalist who reported on the Wuhan COVID outbreak and covered government efforts to control information on the lack of action. Zhang Zhan, a 37-year-old former lawyer and citizen journalist arrested in May while reporting from Wuhan, has been sentenced to four years in jail. 

Zhang was arrested for “picking quarrels and provoking trouble” – an accusation commonly used against dissidents, activists, and journalists – with her video and blog reports from the Wuhan lockdown. 

Even more recent is the extended article in the New Yorker by Lawrence Wright in which he points to key events that might have lessened the extent of the pandemic and in which he reports on a conversation in early 2020 between the heads of the U.S. and People’s Republic of China Centers for Disease Control and Prevention. 

This is how he describes the conversation that occurred on January 3, 2020, when Robert Redfield, the director of the Centers for Disease Control and Prevention, spoke with George Fu Gao, the head of the Chinese Center for Disease Control and Prevention. To be noted: the Chinese CDC is modeled on the American institution. 

At that point in time, Redfield had just received a report about an unexplained respiratory virus emerging in the city of Wuhan.

We have to remember that the field of public health had long been haunted by the prospect of a widespread respiratory illness outbreak like the 1918 influenza pandemic, so Redfield was obviously concerned. 

His Chinese counterpart, Gao, when pressed, assured him that “there was no evidence of human-to-human transmission” (!). When Redfield offered to send a C.D.C. team to Wuhan to investigate, Gao replied that “he wasn’t authorized to accept such assistance.”
.
The author of the article does not indicate whether he talked with Gao to confirm the description of the exchanges but let us take it as a given that such a conversation did take place in early January 2020.

Further insight into George Gao can be gleaned from emails recently published in the Washington Post between Gao and Dr. Anthony Fauci that took place in March-April 2020. It is clear they had a longstanding friendship, professional respect and that Gao wanted to work with NIAID in dealing with COVID-19.

In late 2020, a treasure trove of unreported data became publicly available which showed how much worse the situation was than had been shared by the Chinese Government: 

“In a report marked ‘internal document, please keep confidential,’ local health authorities in the province of Hubei, where the virus was first detected, list a total of 5,918 newly detected cases on February 10, more than double the official public number of confirmed cases, breaking down the total into a variety of subcategories. ”

And on December 28th, it was reported that data released by China’s public health authorities showed that the scale of the coronavirus outbreak in Wuhan, where the virus was first detected last year, “may have been 10 times the official figure…The data also indicate that the city first hit by the virus is also far from achieving herd immunity.”

In short, there can be no excuse for these actions and the incredible harm done, worldwide. But to see this as the full picture of China’s global health performance would also not set the record straight.

The Pretty Good Side

China has been active in global health and in the developing world for decades, with some viewing its efforts as a means to extend its political and economic influence.  That said, it has provided substantial assistance and support for low- and middle-income countries, and notions that would be of benefit for all. 

The same George Gao who spoke with his American counterpart in early January 2020, is also one of the major supportive global health voices for China, recognized and respected as a scientist and forward thinker. For example, in an article in 2017 in the National Science Review, he said this about One World, One Health, expressing his strong support for “international collaboration”:

“Gao: Indeed. We are definitely seeing more infectious diseases. There are many drivers for this, such as human behavior changes, ecological changes, climate change, and globalization. Now people travel everywhere. Once a pathogen emerges, it can spread rapidly—just an overnight flight from Africa to China—posing a big challenge to combating infectious diseases… International collaboration is absolutely important because pathogens have no respect for national borders. This is especially important in a globalized world and with the level of international travel we have now. The challenges, however, are immense—from sharing specimens, political sensitivities to international tourism.”

In the photo: Gao Fu, head of Chinese CDC speaks to journalists after a press conference at State Council Information Office, Beijing, revealing he has been injected with an experimental vaccine. Source: AP July 28, 2020

Further, China was and is an early supporter of the Africa Centers for Disease Control and Prevention (Africa CDC), established by the African Union in 2017. It has been contributing both technical assistance and infrastructure financing. 

Many see this new institution as the means whereby Africa will significantly improve its coordinated disease surveillance, information sharing, and infectious disease analysis and response. In December 2020, the groundbreaking of the Africa CDC headquarters building occurred with Chinese financing. Unsurprisingly, George Gao has been a leading Chinese advisor and supporter of the Africa CDC.

With regards to global efforts to develop and distribute COVID vaccines, in October 2020 China joined all major countries but one (the United States notably didn’t join) in committing to help low- and middle-income countries obtain equitable treatment and reduced costs for vaccines, through COVAX, part of a multi-billion World Health Organization organized effort, the Access to Coronavirus Tools-Accelerator.

China has already produced a number of COVID vaccines which it has been testing on its population but for which the safety trials have not been completed, or at the very least, results not evaluated by external authorities in terms of efficiency, safety, and extent of adverse side effects. Indeed, the latest news is that local governments in China are all set to vaccinate 50 million people by early next year but the vaccines have not yet been officially approved.

That said the United Arab Republic has already approved one of the Chinese vaccines and 100,000 people have received it, along with similar trials in Brazil.

Reports are that from Asia to Africa, including Malaysia and the Philippines and a number of African countries, China has granted priority access to the coronavirus vaccines currently under development. Chinese companies have also reportedly signed agreements with some of these developing nations to test and manufacture the vaccines. All this has led some observers to express concern that China may be using vaccines to expand its soft power.

The Future: When China becomes the largest world power, will it be a responsible partner?

In 2028 China is projected to overtake the United States as the largest world economy (CBER). This is expected to happen a decade sooner than it had been projected a year ago. One reason is that it looks like it will be outperforming the United States during the covid pandemic. 

The acceleration is remarkable.

One can hope China will choose to join the global commons and be a helpful, collaborative partner, including in global health matters, and act in a much more transparent manner to benefit us all. 

That should be the side of China one would wish to see prevail. 


EDITOR’S NOTE: The opinions expressed here by Impakter.com columnists are their own, not those of Impakter.com. Featured Image: Chinese Center for Disease Control, Source: Chinese CDC

Tags: Access to Coronavirus Tool-AcceleratorCDCchinaChinese Center for Disease Control and PreventionCOVID-19Zhang Zhan
Previous Post

De-constructing Modern Democracy

Next Post

Disconnect your Life

Related Posts

Farewell to Soft Power
Politics & Foreign Affairs

Farewell to Soft Power

The Caribbean and the Arctic seem to have little in common. The same cannot be said of Venezuela and Greenland,...

byRichard Seifman
February 20, 2026
One Health in the media
Biodiversity

One Health in the Media: Why Coverage Must Improve

As global attention has pivoted to other issues, including security tensions, trade competition, artificial intelligence, and a host of other...

byRichard Seifman
February 13, 2026
The uncertainty created by anti-ESG statutes has complicated compliance and contract bidding strategies, particularly for firms operating across multiple states with divergent policy approaches.
Climate Change

Texas Anti-ESG Law Declared Unconstitutional

This Week's Regulatory Updates U.S. Judge Strikes Down Texas Anti-ESG Law: A federal judge has declared Texas’ anti-ESG investment law...

byRichard Seifman
February 13, 2026
ESG News regarding EU ban on destruction of unsold clothes and shoes, UK securing record solar capacity, EDF’s ‘fish disco’ system potentially saving 90% of fish, and LNG demand in China setting to climb.
Business

EU Moves to End Textile Waste

Today’s ESG Updates EU Bans Unsold Clothes Destruction: New rules aim to cut CO₂ by stopping companies from discarding apparel...

byRichard Seifman
February 10, 2026
Germany blocks Amazon price caps in e-commerce
Business

Germany’s Cartel Office Slaps Amazon Over Price Caps

This Week’s Regulatory Updates Germany bans Amazon price caps: The Bundeskartellamt demands Amazon halt anti-competitive pricing and repay millions, signaling...

byRichard Seifman
February 6, 2026
ESG news regarding Merz targeting Middle East deals to reduce Germany’s U.S. energy dependence, oil rising after U.S.-Iran drone incident, Amazon committing to 110 MW of German offshore wind power, and Chinese solar stocks surging after Elon Musk team visits local firms.
Business

Merz Visits Middle East to Curb Germany’s Energy Dependence on the U.S.

Today’s ESG Updates Merz Seeks Middle East Deals to Cut U.S. Energy Dependence: Germany’s LNG imports from the U.S. hit...

byRichard Seifman
February 4, 2026
ESG news regarding: New Report Urges Urgent Action to Halt PFAS Contamination Across EU, US Proposes New Rule to Force Greater Transparency in Pharmacy Benefit Manager Fees, EU and Brazil Seal Landmark Deal Creating World’s Largest Free Data Flow Zone, Beijing Suspends Import and Use of Sun Pharma Alzheimer’s Treatment
ESG News

Without Regulation, ‘Forever Chemicals’ Will Cost Europe €440 billion by Mid Century

Today’s ESG Updates Europe Faces Trillion-Euro Risk Without Swift PFAS Controls: The European Commission confirmed it will accelerate work on...

byRichard Seifman
January 30, 2026
ESG News on India lithium and nickel processing incentives and EV battery supply chains
Business

India Plans Incentives for Lithium and Nickel Processing

Today’s ESG Updates India Boosts Lithium & Nickel Processing: India plans incentives for lithium and nickel processing plants to strengthen...

byRichard Seifman
January 29, 2026
Next Post
Disconnect your Life

Disconnect your Life

Recent News

A woman going through the checking account guide

How Checking Accounts Work: Simple Steps to Get Started Fast

February 20, 2026
Coal plants get reprieve on mercury limits, Striking unions fail to halt Milei's sweeping labor bill, Sweden's regulator reviews Swedbank's compliance controls, France backs INEOS decarbonization with €300M

Trump Admin Weakens Coal Plant Mercury Regulations

February 20, 2026
Crowds and filmmakers on the red carpet at the 76th Berlin International Film Festival in 2026

At Berlinale 2026, Artists Refuse the Comfort of Neutrality

February 20, 2026
  • ESG News
  • Sustainable Finance
  • Business

© 2025 Impakter.com owned by Klimado GmbH

No Result
View All Result
  • Environment
    • Biodiversity
    • Climate Change
    • Circular Economy
    • Energy
  • FINANCE
    • ESG News
    • Sustainable Finance
    • Business
  • TECH
    • Start-up
    • AI & Machine Learning
    • Green Tech
  • Industry News
    • Entertainment
    • Food and Agriculture
    • Health
    • Politics & Foreign Affairs
    • Philanthropy
    • Science
    • Sport
  • Editorial Series
    • SDGs Series
    • Shape Your Future
    • Sustainable Cities
      • Copenhagen
      • San Francisco
      • Seattle
      • Sydney
  • About us
    • Company
    • Team
    • Partners
    • Write for Impakter
    • Contact Us
    • Privacy Policy

© 2025 Impakter.com owned by Klimado GmbH